Skip to main content
Erschienen in: Endocrine 1/2010

01.02.2010 | Original Article

Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma

verfasst von: Dong Won Yi, Sun Young Kim, Dong Hoon Shin, Yang Ho Kang, Seok Man Son

Erschienen in: Endocrine | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Abstract

A 61-year-old woman was referred to our department for evaluation of an incidental adrenal mass. An abdominal CT scan revealed a 4.1 cm right adrenal mass. The patient had been diagnosed with hypertension 7 years earlier and had taken antihypertensive medications intermittently. Her physical examination demonstrated a round face, central obesity, and mild hypertension. Serum catecholamines, renin, aldosterone, ACTH and 24-h urine-free cortisol, vanillylmandelic acid levels were within normal limits. However, serum cortisol level was markedly elevated and the circadian rhythm was disturbed. Successive low-dose and high-dose dexamethasone suppression tests were ordered for evaluation of a functioning adrenal incidentaloma. About 2 h after taking the second dose of 2 mg dexamethasone, she suddenly developed nausea and vomiting, palpitations, and anxiety with severe hypertension. On the same day, we measured serum catecholamines, which were markedly elevated. An elective laparoscopic right adrenalectomy was performed and pathologic examination confirmed the diagnosis of pheochromocytoma. One week after surgery, serum and urine catecholamine levels returned to normal. The patient has remained normotensive without any medications and clinically well. Patients with adrenal incidentalomas may have a functional mass that does not always manifest as a full symptomatic disease. During the investigation of adrenal incidentalomas, pheochromocytoma should ideally be ruled out before administering corticosteroids.
Literatur
1.
Zurück zum Zitat W.F. Young Jr, Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol. Metab. Clin. North Am. 29, 159–185 (2000)CrossRefPubMed W.F. Young Jr, Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol. Metab. Clin. North Am. 29, 159–185 (2000)CrossRefPubMed
2.
Zurück zum Zitat M.G. Sutton, S.G. Sheps, J.T. Lie, Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin. Proc. 56, 354–360 (1981)PubMed M.G. Sutton, S.G. Sheps, J.T. Lie, Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin. Proc. 56, 354–360 (1981)PubMed
3.
Zurück zum Zitat E.L. Bravo, R. Tagle, Pheochromocytoma: state-of-the-art and future prospects. Endocr. Rev. 24, 539–553 (2003)CrossRefPubMed E.L. Bravo, R. Tagle, Pheochromocytoma: state-of-the-art and future prospects. Endocr. Rev. 24, 539–553 (2003)CrossRefPubMed
4.
Zurück zum Zitat L.B. Page, J.W. Raker, F.R. Berberich, Pheochromocytoma with predominant epinephrine secretion. Am. J. Med. 47, 648–652 (1969)CrossRefPubMed L.B. Page, J.W. Raker, F.R. Berberich, Pheochromocytoma with predominant epinephrine secretion. Am. J. Med. 47, 648–652 (1969)CrossRefPubMed
5.
Zurück zum Zitat D.J. Cowley, D.A. Montgomery, R.B. Welbourn, Management of paroxysms of hypertension in patients with phaeochromocytomas. Br. J. Surg. 57, 832–834 (1970)CrossRefPubMed D.J. Cowley, D.A. Montgomery, R.B. Welbourn, Management of paroxysms of hypertension in patients with phaeochromocytomas. Br. J. Surg. 57, 832–834 (1970)CrossRefPubMed
6.
7.
Zurück zum Zitat S.N. Kothari, W.A. Kisken, Dexamethasone-induced congestive heart failure in a patient with dilated cardiomyopathy caused by occult pheochromocytoma. Surgery 123, 102–105 (1998)PubMed S.N. Kothari, W.A. Kisken, Dexamethasone-induced congestive heart failure in a patient with dilated cardiomyopathy caused by occult pheochromocytoma. Surgery 123, 102–105 (1998)PubMed
8.
Zurück zum Zitat S. Takagi, S. Miyazaki, T. Fujii, S. Daikoku, Y. Sutani, I. Morii, S. Yasuda, Y. Goto, H. Nonogi, Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn. Circ. J. 64, 785–788 (2000)CrossRefPubMed S. Takagi, S. Miyazaki, T. Fujii, S. Daikoku, Y. Sutani, I. Morii, S. Yasuda, Y. Goto, H. Nonogi, Dexamethasone-induced cardiogenic shock rescued by percutaneous cardiopulmonary support (PCPS) in a patient with pheochromocytoma. Jpn. Circ. J. 64, 785–788 (2000)CrossRefPubMed
9.
Zurück zum Zitat H. Brown, P.A. Goldberg, J.G. Selter, H.S. Cabin, N.J. Marieb, R. Udelsman, J.F. Setaro, Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J. Clin. Endocrinol. Metab. 90, 563–569 (2005)CrossRefPubMed H. Brown, P.A. Goldberg, J.G. Selter, H.S. Cabin, N.J. Marieb, R. Udelsman, J.F. Setaro, Hemorrhagic pheochromocytoma associated with systemic corticosteroid therapy and presenting as myocardial infarction with severe hypertension. J. Clin. Endocrinol. Metab. 90, 563–569 (2005)CrossRefPubMed
10.
Zurück zum Zitat A.L. Rosas, A.A. Kasperlik-Zaluska, L. Papierska, B.L. Bass, K. Pacak, G. Eisenhofer, Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur. J. Endocrinol. 158, 423–429 (2008)CrossRefPubMed A.L. Rosas, A.A. Kasperlik-Zaluska, L. Papierska, B.L. Bass, K. Pacak, G. Eisenhofer, Pheochromocytoma crisis induced by glucocorticoids: a report of four cases and review of the literature. Eur. J. Endocrinol. 158, 423–429 (2008)CrossRefPubMed
11.
Zurück zum Zitat N. Takahashi, T. Shimada, K. Tanabe, H. Yoshitomi, Y. Murakami, Y. Ishibashi, R. Kikkawa, S. Yano, A. Araki, A. Inoue, Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: a case report and review. Int. J. Cardiol. doi: 10.1016/j.ijcard.2008.12.183 (2009) N. Takahashi, T. Shimada, K. Tanabe, H. Yoshitomi, Y. Murakami, Y. Ishibashi, R. Kikkawa, S. Yano, A. Araki, A. Inoue, Steroid-induced crisis and rhabdomyolysis in a patient with pheochromocytoma: a case report and review. Int. J. Cardiol. doi: 10.​1016/​j.​ijcard.​2008.​12.​183 (2009)
12.
Zurück zum Zitat F. Rashid-Farokhi, A. Cheraghvandi, M.R. Masjedi, Pheochromocytoma crisis due to glucocorticoid administration: a case report and review of the literature. Arch. Iran. Med. 12, 190–194 (2009)PubMed F. Rashid-Farokhi, A. Cheraghvandi, M.R. Masjedi, Pheochromocytoma crisis due to glucocorticoid administration: a case report and review of the literature. Arch. Iran. Med. 12, 190–194 (2009)PubMed
13.
Zurück zum Zitat J. Axelrod, Purification and properties of phenylethanolamine-N-methyl transferase. J. Biol. Chem. 237, 1657–1660 (1962)PubMed J. Axelrod, Purification and properties of phenylethanolamine-N-methyl transferase. J. Biol. Chem. 237, 1657–1660 (1962)PubMed
14.
Zurück zum Zitat R.J. Wurtman, Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal specificity and dose-response characteristics. Endocrinology. 79, 608–614 (1966)CrossRefPubMed R.J. Wurtman, Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: hormonal specificity and dose-response characteristics. Endocrinology. 79, 608–614 (1966)CrossRefPubMed
15.
Zurück zum Zitat R. Goodman, D. Edgar, H. Thoenen, W. Wechsler, H. Herschman, Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma. J. Cell Biol. 78, R1–R7 (1978)CrossRefPubMed R. Goodman, D. Edgar, H. Thoenen, W. Wechsler, H. Herschman, Glucocorticoid induction of tyrosine hydroxylase in a continuous cell line of rat pheochromocytoma. J. Cell Biol. 78, R1–R7 (1978)CrossRefPubMed
16.
Zurück zum Zitat A.S. Tischler, R.L. Perlman, G.M. Morse, B.E. Sheard, Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J. Neurochem. 40, 364–370 (1983)CrossRefPubMed A.S. Tischler, R.L. Perlman, G.M. Morse, B.E. Sheard, Glucocorticoids increase catecholamine synthesis and storage in PC12 pheochromocytoma cell cultures. J. Neurochem. 40, 364–370 (1983)CrossRefPubMed
17.
Zurück zum Zitat A. McMahon, E.L. Sabban, Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J. Neurochem. 59, 2040–2047 (1992)CrossRefPubMed A. McMahon, E.L. Sabban, Regulation of expression of dopamine beta-hydroxylase in PC12 cells by glucocorticoids and cyclic AMP analogues. J. Neurochem. 59, 2040–2047 (1992)CrossRefPubMed
18.
Zurück zum Zitat J.A. Critchley, C.G. Henderson, L.E. Moffat, A. Ungar, J. Waite, C.P. West, Proceedings: The release of catecholamines from perfused canine adrenal glands by corticosteroids. J. Physiol. 254, 30–31 (1976) J.A. Critchley, C.G. Henderson, L.E. Moffat, A. Ungar, J. Waite, C.P. West, Proceedings: The release of catecholamines from perfused canine adrenal glands by corticosteroids. J. Physiol. 254, 30–31 (1976)
19.
Zurück zum Zitat G.S. Kurland, A.S. Freedberg, The potentiating effect of ACTH and of cortisone of pressor response to intravenous infusion of L-nor-epinephrine. Proc. Soc. Exp. Biol. Med. 78, 28–31 (1951)PubMed G.S. Kurland, A.S. Freedberg, The potentiating effect of ACTH and of cortisone of pressor response to intravenous infusion of L-nor-epinephrine. Proc. Soc. Exp. Biol. Med. 78, 28–31 (1951)PubMed
20.
Zurück zum Zitat M.E. Ullian, The role of corticosteroids in the regulation of vascular tone. Cardiovasc. Res. 41, 55–64 (1999)CrossRefPubMed M.E. Ullian, The role of corticosteroids in the regulation of vascular tone. Cardiovasc. Res. 41, 55–64 (1999)CrossRefPubMed
21.
Zurück zum Zitat J.A. Whitworth, C.G. Schyvens, Y. Zhang, M.C. Andrews, G.J. Mangos, J.J. Kelly, The nitric oxide system in glucocorticoid-induced hypertension. J. Hypertens. 20, 1035–1043 (2002)CrossRefPubMed J.A. Whitworth, C.G. Schyvens, Y. Zhang, M.C. Andrews, G.J. Mangos, J.J. Kelly, The nitric oxide system in glucocorticoid-induced hypertension. J. Hypertens. 20, 1035–1043 (2002)CrossRefPubMed
22.
Zurück zum Zitat J.W. Lenders, K. Pacak, M.M. Walther, W.M. Linehan, M. Mannelli, P. Friberg, H.R. Keiser, D.S. Goldstein, G. Eisenhofer, Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434 (2002)CrossRefPubMed J.W. Lenders, K. Pacak, M.M. Walther, W.M. Linehan, M. Mannelli, P. Friberg, H.R. Keiser, D.S. Goldstein, G. Eisenhofer, Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 287, 1427–1434 (2002)CrossRefPubMed
23.
Zurück zum Zitat A.M. Sawka, R. Jaeschke, R.J. Singh, W.F. Young Jr, A comparison of biochemical tests for pheochromocytoma: measurements of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J. Clin. Endocrinol. Metab. 88, 553–558 (2003)CrossRefPubMed A.M. Sawka, R. Jaeschke, R.J. Singh, W.F. Young Jr, A comparison of biochemical tests for pheochromocytoma: measurements of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J. Clin. Endocrinol. Metab. 88, 553–558 (2003)CrossRefPubMed
24.
Zurück zum Zitat A.A. Kasperlik-Zeluska, E. Rosłonowska, J. Słowinska-Srzednicka, B. Migdalska, W. Jeske, A. Makowska, H. Snochowska, Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin. Endocrinol. (Oxf) 46, 29–37 (1997)CrossRef A.A. Kasperlik-Zeluska, E. Rosłonowska, J. Słowinska-Srzednicka, B. Migdalska, W. Jeske, A. Makowska, H. Snochowska, Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin. Endocrinol. (Oxf) 46, 29–37 (1997)CrossRef
25.
Zurück zum Zitat A. Miyajima, J. Nakashima, S. Baba, M. Tachibana, K. Nakamura, M. Murai, Clinical experience with incidentally discovered pheochromocytoma. J. Urol. 157, 1566–1568 (1997)CrossRefPubMed A. Miyajima, J. Nakashima, S. Baba, M. Tachibana, K. Nakamura, M. Murai, Clinical experience with incidentally discovered pheochromocytoma. J. Urol. 157, 1566–1568 (1997)CrossRefPubMed
26.
Zurück zum Zitat L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macrì, M. Boscaro, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 83, 55–62 (1998)CrossRefPubMed L. Barzon, C. Scaroni, N. Sonino, F. Fallo, M. Gregianin, C. Macrì, M. Boscaro, Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. J. Clin. Endocrinol. Metab. 83, 55–62 (1998)CrossRefPubMed
27.
Zurück zum Zitat N.B. Tütüncü, O. Gedik, Adrenal incidentaloma: report of 33 cases. J. Surg. Onco. 70, 247–250 (1999)CrossRef N.B. Tütüncü, O. Gedik, Adrenal incidentaloma: report of 33 cases. J. Surg. Onco. 70, 247–250 (1999)CrossRef
28.
Zurück zum Zitat W.M. Manger, R.W. Gifford Jr., Pheochromocytoma: current diagnosis and management. Cleve. Clin. J. Med. 60, 365–378 (1993)PubMed W.M. Manger, R.W. Gifford Jr., Pheochromocytoma: current diagnosis and management. Cleve. Clin. J. Med. 60, 365–378 (1993)PubMed
29.
Zurück zum Zitat U. Guller, J. Turek, S. Eubanks, E.R. Delong, D. Oertli, J.M. Feldman, Detecting pheochromocytoma: defining the most sensitive test. Ann. Surg. 243, 102–107 (2006)CrossRefPubMed U. Guller, J. Turek, S. Eubanks, E.R. Delong, D. Oertli, J.M. Feldman, Detecting pheochromocytoma: defining the most sensitive test. Ann. Surg. 243, 102–107 (2006)CrossRefPubMed
Metadaten
Titel
Pheochromocytoma crisis after a dexamethasone suppression test for adrenal incidentaloma
verfasst von
Dong Won Yi
Sun Young Kim
Dong Hoon Shin
Yang Ho Kang
Seok Man Son
Publikationsdatum
01.02.2010
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2010
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-009-9303-y

Weitere Artikel der Ausgabe 1/2010

Endocrine 1/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.